Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Recently approved immune checkpoint inhibitor therapies are now increasingly used for a variety of ...
THE addition of yet another volume to works on diseases of the endocrine glands can only fill the expert reader with dismay, unless such a work has outstanding characters. The work at present under ...
Women who have close family members with endocrine diseases, including type 2 diabetes, thyroid diseases and polycystic ovary syndrome (PCOS), are at higher risk of pregnancy loss, a new study has ...
Today, 15 May 2023, the European Society of Endocrinology (ESE), the European Hormone and Metabolism Foundation (ESE Foundation) and other partners are marking the second European Hormone Day.
Please provide your email address to receive an email when new articles are posted on . ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on ...
Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...
The pancreas produces endocrine hormones and pancreatic digestive enzymes. The hormone function is called the endocrine pancreas. Insulinomas are tumors on the pancreas that cause the tumor to make ...
SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of ...
The European Society for Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) have released today, 17 October 2025, the EndoCompass Research Roadmap: Directions for the ...
A study using a large Korean health database found that people with a rare hair loss disorder called primary cicatricial alopecia were more likely to also have additional health problems like diabetes ...
COPENHAGEN, Denmark, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results